Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Burning Rock Biotech (BNR) EBIT: 2019-2024

Historic EBIT for Burning Rock Biotech (BNR) over the last 6 years, with Dec 2024 value amounting to -$49.0 million.

  • Burning Rock Biotech's EBIT rose 483.73% to $20.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$30.5 million, marking a year-over-year decrease of 118.34%. This contributed to the annual value of -$49.0 million for FY2024, which is 48.04% up from last year.
  • According to the latest figures from FY2024, Burning Rock Biotech's EBIT is -$49.0 million, which was up 48.04% from -$94.3 million recorded in FY2023.
  • Burning Rock Biotech's EBIT's 5-year high stood at -$49.0 million during FY2024, with a 5-year trough of -$142.1 million in FY2022.
  • Moreover, its 3-year median value for EBIT was -$94.3 million (2023), whereas its average is -$95.1 million.
  • In the last 5 years, Burning Rock Biotech's EBIT slumped by 158.09% in 2020 and then surged by 48.04% in 2024.
  • Over the past 5 years, Burning Rock Biotech's EBIT (Yearly) stood at -$63.2 million in 2020, then tumbled by 97.89% to -$125.1 million in 2021, then declined by 13.65% to -$142.1 million in 2022, then skyrocketed by 33.68% to -$94.3 million in 2023, then surged by 48.04% to -$49.0 million in 2024.